These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 6594782

  • 21. Experience with intermediate- and high-dose cytosine arabinoside in relapsed and refractory acute leukaemia.
    Willemze R, Fibbe WE, Zwaan FE.
    Neth J Med; 1983; 26(8):215-9. PubMed ID: 6580554
    [No Abstract] [Full Text] [Related]

  • 22. Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.
    Rivera G, Aur RJ, Dahl GV, Pratt CB, Wood A, Avery TL.
    Cancer; 1980 Mar 15; 45(6):1284-8. PubMed ID: 7357520
    [Abstract] [Full Text] [Related]

  • 23. Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.
    Rivera G, Avery T, Roberts DW.
    Eur J Cancer (1965); 1975 Sep 15; 11(9):639-47. PubMed ID: 1220978
    [No Abstract] [Full Text] [Related]

  • 24. [Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
    Masi M, Vivarelli F, Paolucci P, Vecchi V.
    Minerva Pediatr; 1975 Sep 15; 27(28):1539-50. PubMed ID: 1101022
    [No Abstract] [Full Text] [Related]

  • 25. The present of situation in treatment and prognosis of childhood acute lymphocytic leukemia with an outlook for the future.
    Simone JV.
    Haematologica; 1982 Jun 15; 67(3):329-34. PubMed ID: 6814989
    [No Abstract] [Full Text] [Related]

  • 26. [Phase I trial and pharmacokinetics of VM 26 combined with cisplatin administered by the intraperitoneal route without mixing time].
    Chatelut E, Canal P, De Forni M, Chevreau C, Houin G, Bugat R.
    Bull Cancer; 1989 Jun 15; 76(8):893-6. PubMed ID: 2620120
    [No Abstract] [Full Text] [Related]

  • 27. Remission continuation therapy for adult acute lymphoblastic leukemia. Preliminary results with a multidrug treatment protocol.
    Rossi G, Verzura P, Marpicati P, Zaniboni A, Ferremi P, Marini G, Marinone G.
    Chemioterapia; 1984 Jun 15; 3(3):147-51. PubMed ID: 6597732
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. High-dose Ara-C plus VM-26 in adult acute lymphoblastic leukemia.
    Larson RA, Gaynor ER, Shepard KV, Daly KM.
    Eur J Cancer Clin Oncol; 1985 Oct 15; 21(10):1261-3. PubMed ID: 3865776
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Teniposide: a review of 12 years of experience.
    O'Dwyer PJ, Alonso MT, Leyland-Jones B, Marsoni S.
    Cancer Treat Rep; 1984 Dec 15; 68(12):1455-66. PubMed ID: 6391663
    [No Abstract] [Full Text] [Related]

  • 36. [Experiences in the treatment of immature cell leukemias with cytosine arabinoside and daunorubidomycin].
    Schmalzl F, Braunsteiner H.
    Wien Klin Wochenschr; 1971 Jun 25; 83(25):452-6. PubMed ID: 5289111
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
    Savchenko VG, Parovichnikova EN, Isaev VG, Kulimova EP, Kucher RA, Sokolov AN, Ustinova EN, Gribanova EO, Khoroshko ND, Pivnik AV, Tikhonova LIu, Sarkisian GP, Domracheva EV, Maslova ER, Konstantinova TS, Rekhtman GB, Lapin VA, Miliutina TI.
    Ter Arkh; 2001 Jun 25; 73(7):6-15. PubMed ID: 11523412
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.